Evidence map›Paper›PMID 40437020›Full record

ArticleBritish journal of cancer2025

CD49a

Kele Cui, Shouxin Hu, Yanfang Zha, Keshuo Ding, Haiming Wei, Min Cheng, Xinyu Mei

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Kele CuiDepartment of Clinical Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Shouxin HuDepartment of Geriatrics, Gerontology Institute of Anhui Province, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yanfang ZhaDepartment of Geriatrics, Gerontology Institute of Anhui Province, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Keshuo DingDepartment of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, China.
Haiming WeiThe Institute of Immunology, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. ustcwhm@ustc.edu.cn.ORCID http://orcid.org/0000-0002-1675-6502
Min ChengDepartment of Geriatrics, Gerontology Institute of Anhui Province, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. chengmin@ustc.edu.cn.
Xinyu MeiDepartment of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. mxyahslyy@ustc.edu.cn.ORCID http://orcid.org/0000-0003-4272-216X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82171546
6 · The paper itself

Abstract

backgroundAlthough extensive evidence indicates that tissue-resident natural killer (trNK) cells are closely related to the development and clinical outcomes of various tumours, their roles in esophageal cancer remain obscure.

methodsTumour tissues collected from 54 esophageal squamous cell carcinoma (ESCC) patients during surgery and human ESCC tissue arrays including samples from 258 patients were subjected to analyse the phenotype and functions of immune cells.

resultsWe observed a population of CD49a

conclusionsOur research reveals that tumour-infiltrated CD49a

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaGranulocyte-Macrophage Colony-Stimulating FactorKiller Cells, NaturalMyeloid-Derived Suppressor CellsFemaleHumansMaleMiddle AgedPrognosisTumor MicroenvironmentGranulocyte-Macrophage Colony-Stimulating Factor

Identifiers

PMID40437020
PMCPMC12322211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.